| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.011 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |